ReviewInternational journal of molecular sciences2022

Metabolic Reprogramming in Sickle Cell Diseases: Pathophysiology and Drug Discovery Opportunities.

Dina Alramadhani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.